+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Neoeriocitrin

BPF2304
13241-32-2
98%
普瑞法
Aurantii fructus immaturus
Neoeriocitrin is a flavanone glycoside that is eriodictyol substituted by a 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl residue at position 7 via a glycosidic linkage. It has a role as a plant metabolite. It is a member of 4'-hydroxyflavanones, a neohesperidoside, a trihydroxyflavanone, a disaccharide derivative and a flavanone glycoside. It is functionally related to an eriodictyol. Neoeriocitrin has antioxidant capacity, it could rescue the inhibition effect of cell differentiation induced by PD98059 to some degree.Neoeriocitrin may be a new promising candidate drug for treatment of osteoporosis.
Catalog No Package Original Price Price Inventory Quantity Operating
BPF2304-10mg 10mg
BPF2304-20mg 20mg
BPF2304-100mg 100mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

TNF PTGS2 NFKB1 IL6 IL1B
NFE2L2 PPARG NFKB1 SOD1 CAT GPX1 HMOX1

Product drug property prediction parameters

  • 245.2900

  • -.1965

  • -.2357

  • 7.5162

  • .4977

  • .1043

  • Low

  • 70.5580

  • 4.8388

  • Yes

  • No

  • No

  • No

  • No

  • No

  • 0.0

  • Yes

  • No

  • Yes

  • No